Should Value Investors Buy Universal Health Services (UHS) Stock?
Werte in diesem Artikel
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.Universal Health Services (UHS) is a stock many investors are watching right now. UHS is currently holding a Zacks Rank #2 (Buy) and a Value grade of A. The stock is trading with P/E ratio of 9.01 right now. For comparison, its industry sports an average P/E of 13.27. Over the past 52 weeks, UHS's Forward P/E has been as high as 14.67 and as low as 8.03, with a median of 10.46. Investors will also notice that UHS has a PEG ratio of 0.71. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. UHS's industry has an average PEG of 1.37 right now. UHS's PEG has been as high as 0.93 and as low as 0.48, with a median of 0.62, all within the past year.Finally, we should also recognize that UHS has a P/CF ratio of 6.77. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 7.44. Within the past 12 months, UHS's P/CF has been as high as 10.90 and as low as 5.80, with a median of 7.34.These are just a handful of the figures considered in Universal Health Services's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that UHS is an impressive value stock right now.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Universal Health Services, Inc. (UHS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Universal Health Services und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Universal Health Services
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Universal Health Services
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Universal Health Services Inc.
Analysen zu Universal Health Services Inc.
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
27.02.2017 | Universal Health Services Neutral | Mizuho | |
09.11.2016 | Universal Health Services Neutral | Mizuho | |
21.04.2016 | Universal Health Services Hold | Standpoint Research | |
29.10.2015 | Universal Health Services Equal Weight | Barclays Capital | |
03.08.2015 | Universal Health Services Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.02.2007 | Universal Health underperform | Bear Stearns | |
31.08.2005 | Update Universal Health Services Inc.: Underperfor | Goldman Sachs | |
31.08.2005 | Universal Health underperform | Goldman Sachs | |
24.01.2005 | Update Universal Health Services Inc.: Reduce | UBS |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Universal Health Services Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen